STERIS plc (Ireland) ($STE) Stock Forecast: Up 8.7% Today

What is STERIS plc (Ireland)?

STERIS (STE) is a company in the healthcare sector offering infection prevention and procedural products and services, and its stock showed significant upward movement today.

Why is STERIS plc (Ireland) going up?

STE stock is up 8.7% on May 15, 2025 16:45

• STE exceeded Q4 earnings expectations, with increased margins, leading to a rise in the stock price.
• The strong growth in Healthcare and AST revenues played a crucial role in the market's positive response.
• Beating earnings estimates by a notable margin and surprising revenue figures indicated the company's strong performance and potential growth.
• Positive analyst projections and key metrics for STE's Q4 earnings reinforced investor confidence in the stock.

STE Price Chart

STE Technical Analysis

STE News

STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket

STERIS' fourth-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues.

https://www.zacks.com/stock/news/2471798/ste-q4-earnings-beat-margins-expand-stock-up-in-aftermarket

Here's What Key Metrics Tell Us About Steris (STE) Q4 Earnings

Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

https://www.zacks.com/stock/news/2471428/heres-what-key-metrics-tell-us-about-steris-ste-q4-earnings

Steris ( STE ) Surpasses Q4 Earnings Estimates

Steris (STE) delivered earnings and revenue surprises of 5.79% and 0.09%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2471388/steris-ste-surpasses-q4-earnings-estimates

What Analyst Projections for Key Metrics Reveal About Steris ( STE ) Q4 Earnings

Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

https://www.zacks.com/stock/news/2465973/what-analyst-projections-for-key-metrics-reveal-about-steris-ste-q4-earnings

Trending Today

Bitcoin Cash ($BCH) Crypto Forecast: Up 5.8% Today

dogwifhat ($WIF) Crypto Forecast: Up 6.6% Today

Pepe ($PEPE) Crypto Forecast: Up 5.9% Today

Avalanche ($AVAX) Crypto Forecast: Down 5.1% Today

Ondo ($ONDO) Crypto Forecast: Up 5.4% Today

STERIS plc (Ireland) Price History

15.04.2025 - STE Stock was up 8.7%

• STE exceeded Q4 earnings expectations, with increased margins, leading to a rise in the stock price.
• The strong growth in Healthcare and AST revenues played a crucial role in the market's positive response.
• Beating earnings estimates by a notable margin and surprising revenue figures indicated the company's strong performance and potential growth.
• Positive analyst projections and key metrics for STE's Q4 earnings reinforced investor confidence in the stock.

15.04.2025 - STE Stock was up 5.2%

• Steris (STE) outperformed earnings expectations in the fourth quarter, demonstrating robust financial performance.
• Projections from analysts on key metrics suggest a positive trajectory for Steris, bolstering investor confidence.
• Strong financial results exceeding estimates and optimistic analyst forecasts likely fueled today's bullish movement in Steris (STE) stock.
• The company’s solid performance and growth potential may be prompting investors to increase buying activity, consequently driving up the stock price.

07.10.2024 - STE Stock was down 6.1%

• Despite surpassing earnings expectations in Q2, STE observed a downward trend in its stock price, possibly influenced by worries about margin reduction.
• The market's negative response to the margin decline contrasts with the solid revenue expansion in the Healthcare and AST segments.
• Investor sentiment towards the company's outlook appears cautious, as indicated by queries about future stock performance.

07.10.2024 - STE Stock was down 5.0%

• Following an exceedance of Q2 earnings forecasts, Steris encountered a decline in its stock value.
• Market participants potentially anticipated greater company performance or outlook.
• Any apprehensions or uncertainties voiced during the earnings call might have elicited a negative market response.
• Traders could be engaging in profit-taking subsequent to a period of pre-earnings growth.

08.10.2023 - STE Stock was down 6.2%

• Steris PLC reported Q2 revenues that surpassed estimates, indicating continued momentum in the healthcare business. However, margins were down, which may have contributed to the bearish movement.
• Despite beating Q2 top and bottom line estimates, Steris PLC reaffirmed its FY23 outlook, which could have disappointed investors and led to the bearish market movement.
• The earnings summary shows a significant improvement in earnings compared to the same period last year, but the negative EPS in the previous year may have influenced the bearish sentiment.
• The slight beat in estimated earnings and revenue growth may not have met investors' high expectations, resulting in the bearish movement.

09.04.2024 - STE Stock was up 5.1%

• The company reported a loss of $1.4 million in its fiscal Q4 earnings, which was lower than expectations.
• Despite the loss, Steris managed to match Q4 earnings estimates, with a slight revenue surprise.
• The downgrade of Steris from a "buy" rating to a "hold" rating might have initially caused some uncertainty in the market.
• Investors might have reacted positively to the company's ability to meet earnings estimates and the potential for future growth beyond just revenue and EPS, leading to the bullish movement in the stock price.

09.04.2024 - STE Stock was up 6.9%

• The company reported a loss in its fiscal Q4 earnings, aligning with earnings estimates.
• Despite the reported loss, the stock displayed a bullish movement, suggesting investor focus may be on other positive aspects of the company.
• The company was downgraded from a "buy" rating to a "hold" rating by an analyst platform, which typically impacts the stock negatively. However, the market movement remained bullish.
• Investor optimism regarding Steris' competitive strengths and financial metrics could be contributing to the bullish movement despite the mixed earnings report.

31.06.2023 - STE Stock was down 1.6%

• The bearish movement in STE's stock today can be attributed to the news of Nisa Investment Advisors LLC increasing its stake in the company. Despite the positive sentiment shown by Nisa Investment Advisors LLC, the market may have interpreted this as a potential overvaluation of the stock, leading to a sell-off. Additionally, the announcement of a dividend hike may have raised concerns about the company's financial health and sustainability of future dividends, further contributing to the bearish movement.

08.01.2024 - STE Stock was down 5.0%

• Despite STERIS (STE) reporting strong Q3 earnings and beating estimates, the stock experienced a bearish movement.
• The market may have reacted negatively to the fact that the earnings beat was only marginal, with a 2.30% surprise on earnings and a 4.22% surprise on revenues.
• Investors might have been expecting a more significant beat, leading to disappointment and selling pressure on the stock.
• It's possible that the market was also influenced by other factors not mentioned in the provided articles, such as broader market trends or investor sentiment towards the healthcare sector.

26.05.2023 - STE Stock was up 0.5%

• Today, STE had a strong bullish movement. This could be due to the following reasons:
• STE announced the acquisition of surgical instrumentation assets from Becton, Dickinson and Company in a $540 million transaction. This could be seen as a positive move for the company, as it expands their product lineup and could lead to increased revenue.
• Voya Investment Management LLC raised its position in STE shares during the fourth quarter, which could have increased investor confidence in the company.
• STE has been growing and deleveraging its balance sheet since the Cantel deal in 2021, which could be seen as a positive sign for investors.
• The sale of the surgical instrumentation platform by Becton, Dickinson and Company to STE could have been seen as a positive move for both companies, leading to increased investor confidence in STE.

09.06.2024 - STE Stock was down 2.5%

• The current downward trend in STE stock may stem from investor wariness of broader economic challenges.
• Although the AST segment shows strong recovery potential, general economic uncertainties could be outweighing positive outlook.
• Investors appear to be adopting a cautious stance, analyzing the interplay between STE's business strengths and external economic conditions.

07.07.2024 - STE Stock was down 0.4%

• Despite surpassing expectations in earnings and revenue for the first quarter of fiscal 2025, Steris (STE) witnessed a significant downward trend in the market.
• The company's impressive financial results and revenue growth, especially in the healthcare sector, could not counteract the negative impact on its stock.
• The bearish movement in STE stock might have been influenced by shareholders' support for board and auditor proposals, which could have been overshadowed by external market conditions or other unrelated concerns.
• The decline in Steris (STE) stock value could be a result of investors' reactions to external elements or uncertainties ahead, despite the company's robust financial performance.